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Abstract
Human Immunodeficiency Virus 1 uses for entry into host cells a receptor (CD4) and one of two co-receptors (CCR5 or
CXCR4). Recently, a new class of antiretroviral drugs has entered clinical practice that specifically bind to the co-receptor
CCR5, and thus inhibit virus entry. Accurate prediction of the co-receptor used by the virus in the patient is important as it
allows for personalized selection of effective drugs and prognosis of disease progression. We have investigated whether it is
possible to predict co-receptor usage accurately by analyzing the amino acid sequence of the main determinant of co-
receptor usage, i.e., the third variable loop V3 of the gp120 protein. We developed a two-level machine learning approach
that in the first level considers two different properties important for protein-protein binding derived from structural
models of V3 and V3 sequences. The second level combines the two predictions of the first level. The two-level method
predicts usage of CXCR4 co-receptor for new V3 sequences within seconds, with an area under the ROC curve of
0.93760.004. Moreover, it is relatively robust against insertions and deletions, which frequently occur in V3. The approach
could help clinicians to find optimal personalized treatments, and it offers new insights into the molecular basis of co-
receptor usage. For instance, it quantifies the importance for co-receptor usage of a pocket that probably is responsible for
binding sulfated tyrosine.
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Introduction
Specific protein interactions are central to biological processes,
and the infection of cells with viruses is no exception there. In the
case of pathogenic viruses, such protein interactions are potential
targets for medical intervention. An example of particularly high
relevance is Human Immunodeficiency Virus 1 (HIV-1). HIV-1
enters human cells in a process that comprises several steps,
including the binding of the viral gp120 protein to the cellular
receptor protein CD4 and a co-receptor protein, usually one of the
two chemokine receptors CCR5 and CXCR4 [1]. The type of co-
receptor used by the virus, the so-called co-receptor tropism, has a
prognostic value, since patients with a CXCR4-tropic virus (‘‘X4
virus’’) progress faster to Acquired Immunodeficiency Syndrome
(AIDS) compared to patients with a CCR5-tropic virus (‘‘R5
virus’’) [2]. In addition to the purely X4- and R5-tropic viruses,
there are also ‘‘dual-tropic’’ strains, able to use both co-receptors
(‘‘R5X4 virus’’). Recently, the first drug (Maraviroc [3]) that binds
to CCR5, and thus inhibits productive binding of gp120, has been
approved by regulatory authorities in several countries. This has
made the determination of co-receptor tropism directly relevant to
anti-retroviral treatment, as CCR5-inhibitors are of course
inactive against X4 virus.
The standard way of determining co-receptor tropism is by cell-
based assays [4,5]. The main drawbacks of these assays are that
they are currently only carried out by a handful of specialized
laboratories worldwide, and that the overall procedure typically
takes several weeks. These impediments to the wide application of
entry inhibitors could be overcome by an approach similar to
genotypic drug resistance testing [6], where drug resistance of a
viral strain is inferred from comparison of mutational patterns
obtained from sequencing parts of the genome of that strain with
patterns of validated resistance mutations. This is a relatively fast
and cheap standard procedure established in many clinics.
At first glance, genotypic testing for co-receptor tropism seems
to be possible since the main molecular determinant of tropism is
known to be the third variable loop (V3) of the viral glycoprotein
gp120 [7], a peptide stretch of about 35 amino-acids with a
disulfide bridge connecting the terminal cysteins. Unfortunately, as
suggested by its name, V3 is notorious for its high sequence
variability [8] including also some variability in length, and this
has made it difficult to use it as a basis for genotypic co-receptor
tropism testing. Nevertheless, the relevance of the quest has
prompted many groups to develop models that link properties of
V3 to co-receptor tropism. The importance of electrostatics for co-
receptor tropism has been recognized early on, and the best-
known model, the so-called 11/25-rule, refers to charges of V3-
residues 11 and 25: if one of these is positive, then the virus is
CXCR4-tropic [9,10]. This rule has a specificity of more than 0.9
(few false positives), but only a low to moderate sensitivity (many
false negatives) of about 0.4–0.6, depending on the test data, which
is not satisfactory for routine clinical application. To improve
predictions from sequence, several groups have applied machine
learning methods, such as artificial neural networks [11], position
specific scoring matrices [12], decision trees, or support vector
machines [13]. Still, prediction accuracies fall short of what seems
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limited accuracies are the footprint of tropism-determinants
outside V3, or the consequence of model imperfections.
A milestone for the understanding of co-receptor tropism was
the X-ray structure of gp120 with the V3 loop in a biological
context [15]. This paved the way for the development of
prediction methods that use, in addition to V3 sequence, structural
information. To our knowledge, the first of these methods has
been that of Sander et al. [16], which was mainly based on
geometric distances of amino-acid pairs within the structure of V3.
Although our method, detailed in the following, relies on the same
experimental structure by Huang et al. [15], it differs from that of
Sander et al. in several respects, e.g. it deals with indels, and,
perhaps most crucially, it uses as descriptors properties that
directly determine interaction of V3 with the co-receptors. By the
latter we consider a seemingly trivial but fundamental fact that so
far has not been thoroughly exploited: although V3 is highly
variable, all X4-tropic V3 loops share one property, namely, they
preferentially have a physical binding interaction with CXCR4,
while R5-tropic V3 loops preferably interacts with CCR5. The
accuracy of the method makes it attractive as clinical tool for
patient tailored decisions on treatment with entry inhibitors, and it
suggests that co-receptor tropism can be explained almost
exclusively based on V3.
Results/Discussion
Overall Approach
We aim at a computational method that for a given amino acid
sequence of V3 predicts the tropism class ‘‘X4’’ (including dual-
tropics), or ‘‘R5’’. Predictions by the method should have an
accuracy close to 100%, and be robust against the high diversity of
V3, both in terms of sequence and length.
In agreement with experimental data, we based the method on
the assumption that the co-receptor tropism of HIV-1 is
determined by a preferential physical interaction between a V3
loop and one of the co-receptors. We further assumed that both
molecules interact while taking specific conformations. While little
is known about the conformations of the extracellular parts of the
co-receptors, there is a crystal structure available for a CCR5-
tropic V3 loop [15]. In the first step of our approach we therefore
modeled the conformations of V3 sequences of known tropism
using this crystal structure as a template (see Materials and
Methods). The modeled conformations enable the estimation of
spatially distributed physical quantities that contribute to differ-
ential interactions of the V3 loops with the respective co-receptor,
namely the values of the electrostatic potential wi(r),i~1,...,n
around each V3 loop i (‘‘electrostatics hull’’). Using these sets of
wi(r) and the corresponding tropism ‘‘X4’’ and ‘‘R5’’, respectively,
we trained a first random forest [17] classifier. Tropism
classification of unseen V3 sequences is performed by automated
modeling of the new V3 conformation, computation of w(r), and
application of the previously trained random forest. The output is
a probability for the given V3 sequence to belong to the X4 class
(and not to the R5 class).
Although the first step explicitly takes into account conforma-
tion dependent physical properties that are of direct relevance to
the differential interaction with the two co-receptors, we do not
expect a perfect classifier from this first step for a number of
reasons. For example, it is unclear whether the crystal structure is
an appropriate template for all V3 sequences. In fact, V3 is known
to be flexible [18], and there may even be a conformational switch
between X4- and R5-tropic V3 loops [19]. Hence, we trained in a
second step another random forest classifier solely on V3
sequences and with the hydrophobicity scale of Kyte and Doolittle
[20] as descriptor. This descriptor has been derived by
amalgamating several properties of amino-acids into a single
scale, notably experimental results on solubility; it happens also to
map amino-acids of opposite electrical charges to different scale
values. Thus, this second classifier probably captures aspects of the
relation between sequence and tropism that are at least partially
complementary to those considered by the first classifier.
In the final step of our approach, we trained a third random
forest classifier with the two tropism class probabilities obtained
from the previous two steps as input. Thus, application of the
whole approach to an unseen V3 sequence includes application of
a first level set of two random forests considering conformational
and sequence properties, and a second level random forest using
the outcomes of the first level for the final classification.
Application of the classifier to a new V3 sequence to predict its
co-receptor tropism takes a few seconds on a state-of-the-art CPU
core. In the cross-validation, X4 sequences were detected with a
sensitivity of 0:81+0:01 (at a specificity of 0.97), and the area
under the ROC curve (AUC) was 0:937+0:004 (full set of
sequence and tropism data used for training and cross-validation is
provided as Supporting Information). The method is described in
greater detail in the following sections.
Electrostatics Hull
The findings outlined in the introduction are compatible with a
direct physical interaction between V3 and the respective co-
receptor. Specifically, the 11/25 rule and the association of V3 net
charge with tropism [9,10] point to the impact of electrostatics on
co-receptor tropism. In previous work, electrostatics has been
considered in several ways, including the mentioned 11/25 rule,
both alone and in combination with overall net charge [11], and
also more complex relations such as an 11/24/25 rule [21].
Although these phenomenological rules have been helpful in
guiding research, they are too simple to accurately capture the
underlying molecular process, which limits their predictive power.
To develop a more accurate model, we therefore first considered
the one conserved feature that defines each of the tropism classes,
Author Summary
Human Immunodeficiency Virus is the pathogen causing
the disease AIDS. A precondition for virus entry into
human cells is the contact of its glycoprotein gp120 with
two cellular proteins, a receptor and a co-receptor.
Depending on the viral strain, one specific co-receptor is
used. The type of co-receptor used is crucial for the
aggressiveness of the viral strain and the available
treatment options. Hence, it is important to identify which
co-receptor is used by the virus in an individual patient.
Since the genome of the virus in the patient can be readily
sequenced, and thus the composition of the viral proteins
be determined, it could be possible to predict co-receptor
usage from the viral genome sequences. To this end, we
developed a method that is motivated by the insight that
physical properties of gp120 will determine its specificity
for a co-receptor. The method learns a computational
model from structures and sequences of a crucial part of
gp120, and the corresponding experimentally measured
co-receptor usage. It then employs the model to predict
co-receptor usage for new sequences. The high accuracy
of the method could make it helpful for diagnosis and
suggests that the model captures the determinants of co-
receptor usage.
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in particular their electrostatic interaction. Unfortunately, it is
currently not possible to compute electrostatic energies of
complexes of V3 and co-receptors since this necessitates
availability of the structures of these complexes, which are
unknown as yet. Thus, we resorted to the electrostatic potential
w(r) around the V3 loops as alternative descriptor. Fulfillment of
the following three assumptions is sufficient, though not necessary,
to justify the choice of w(r) as descriptor: first, electrostatics is
crucial for preferential interaction; second, the X-ray structure of
the V3 loop from Huang et al. [15] represents the typical
conformation of V3 loops, and conformations of all V3 loops can
be derived as homology models from this X-ray structure; third,
V3 loops bind to the co-receptors in the same binding mode. If
these conditions are satisfied, preferential interactions of V3 loops
with co-receptors can be mapped on differences in w(r), essentially
because different w(r) will in general lead to different interaction
energies
Ð
w(r)r(r)dr with unknown but constant co-receptor
charge densities r(r).
Technically, we restricted computation of w(r) to an ‘‘electro-
statics hull’’, a discretized surface of nhull~642 points in space
around the template V3 structure of Huang et al. [15]. The hull
should be, on one hand, wide enough to enclose all superimposed
V3 loops with a certain safety margin, and, on the other hand,
tight enough to reflect the differences of w(r) from different V3
loops. We obtained good results with a hull in a distance of 0.6 nm
to the solvent accessible surface of the template V3 structure.
Electrostatics-Based Classification
For each V3 sequence i~1,...,nseq of known co-receptor
tropism in the training set, a homology model was generated based
on the template X-ray structure. Then the electrostatic potential
wi(rj) at the points rj of the electrostatics hull was computed by
solving the Poisson-Boltzmann Equation [22]. A random forest
[17] was trained using vectors wi(r1),...,wi(rnhull) ðÞ of length
nhull~642 as input, and as responses the corresponding measured
tropisms ti [ X4,R5 fg , with i~1,...,nseq. Using the leave-one-
patient-out scheme for cross-validation (see ‘‘Materials and
Methods’’) we arrived for this classifier at an AUC of
0:934+0:001 (‘‘ESP’’ in Fig. 1).
The analysis based on the electrostatics hull opens the possibility
of deriving a co-receptor specific pharmacophore pattern of V3
loops. Fig. 2 shows points of the electrostatics hull that are of
highest importance for the classification by the random forest, with
importance here defined as percentage decrease in accuracy in
classification if, for the respective point r of the electrostatics hull,
descriptor values wi(r) are randomly permuted [17]. As could be
expected, some important points cluster in the region around
residues 11, 24, and 25, though their dispersion makes it difficult to
associate them with single residues. The majority of these points
are located on the side to which most of the amino-acid side-chains
point in the crystal structure (see also Supporting Information file
Text S1). Interestingly, there is another important region on the
opposite side of the loop between residues 6 and 30 that may be
involved in the binding of sulfated tyrosines in the N-terminal
region of CCR5 [23].
In Fig. 2 important positions are colored according to average
electrostatic potential SwT in the R5, R5X4, and X4 classes. The
potential around R5-tropic V3 is generally lower as compared to
X4-tropic V3, in particular around residues 24 (in agreement with
the 11/24/25 rule) and 30. The coloring shows that R5X4-tropic
V3 usually have SwT values between those of R5 and X4, while at
a few patches they are chimeras of the mono-tropic classes. The
latter is true between residues 6 and 30 and close to residue 25
where R5X4 on average resembles R5, and around residue 11 and
close to residue 24 where R5X4 is more similar to X4.
Hydrophobicity-Based Classification
The classification based on the values of w on the electrostatics
hull may fail in some cases, e.g. because some V3 sequences could
prefer conformations not adequately represented by the X-ray
structure of Huang et al. [15] that forms the basis of the
electrostatics hull computation. We have therefore trained a
second random forest, basically using as input the Kyte-Doolittle
hydrophobicity values [20] of the residues along the V3 sequences,
and as response again the measured tropisms. The hydrophobicity
scale seemed suitable as it also captures physically motivated
properties that are relevant for binding.
An obstacle to sequence based learning was the high
sequence diversity in our dataset so that standard multiple
sequence alignment methods did not return clear profiles. This
may have been the reason why other groups used for
preparation of sequence data e.g. pairwise alignments to a
reference sequence [11], manual alignments [24], or combi-
nations of computational and manual multiple sequence
alignments [12]; in these methods insertions and deletions
were usually treated ad hoc, e.g. by removing insertions beyond
a sequence length of 35. We have sought a simple algorithm
that considers all sequences in a systematic and automated way
irrespective of sequence length.
This algorithm essentially leads to ‘‘normalized sequences’’ of
uniform length with interpolated hydrophobicity values as
descriptors. In detail, we normalized all sequences to the
maximum length of Nmax~38 occurring in the dataset. In the
normalization procedure each sequence of NƒNmax residues is
first arranged along a continuous pseudo-sequence axis with equal
distances of Nmax{1 ðÞ = N{1 ðÞ between all neighbor residues. If
the first residue is placed at pseudo-sequence position 1, this
equidistant arrangement brings the Nth residue to pseudo-
sequence position Nmax, while the residues in-between are in
general at non-integer positions. In the second step of the
normalization procedure, hydrophobicity values at the integer
positions 1,...,Nmax of the normalized sequence are linearly
interpolated from the neighboring positions of the previously
determined pseudo-sequence and their respective Kyte-Doolittle
values, i.e. if the normalized sequence position i has two neighbors
in the pseudo-sequence at i{d{ and izdz with Kyte-Doolittle
values k{ and kz, respectively, then the hydrophobicity
descriptor value at normalized sequence position i is
k{zd{: kz{k{ ðÞ = dzzd{ ðÞ . This normalization leads to
uniform sequence lengths with a consistent and automated
treatment of insertions and deletions.
Random forests trained on normalized sequences with interpo-
lated Kyte-Doolittle descriptors had an AUC of 0:930+0:001,
and thus about the same prediction performance in cross-
validation as that trained on the electrostatics hull (see Fig. 1).
Fig. 3 shows the distribution of the importance for the random
forest error of the normalized sequence positions 1 to 38, with
importance here defined as percentage decrease in accuracy in
classification if, at the respective normalized sequence position,
descriptor values are randomly permuted [17]. The highest peak
is in the vicinity of position 11, in agreement with the 11/25 rule
(note that in the sequence normalization procedure described
above most sequences are stretched towards the maximum
length of 38, and this stretch shifts position 11 of the amino-acid
sequence towards position 12 of the normalized sequence).
Position 25 does not stick out prominently; in fact, at position 25
of the normalized sequence there is a dip in a broad hill.
HIV Co-Receptor Tropism
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sequence have sizable importance values. The next highest
peaks are around positions 8 and 29. These two positions are
close in space but on opposite sides of the V3 loop in the so-
called stem region (the central bulge of the V3 structure). As
mentioned above, there is evidence [23] that in R5 tropic virus
this region is involved in the binding of sulfated tyrosins near the
N-terminus of CCR5, and that X4 and R5 tropic viruses
interact differentially with these sulfated tyrosins [25].
Second-Level Classification
In Fig. 4 the class probabilities according to the two previously
described random forests are plotted for all V3 sequences in the
dataset. The figure suggests that the two computational models are
in part complementary, as the distribution of both tropism classes
extends into the upper left and lower right quarters. More
importantly for classification, the two sets of R5 and X4/R5X4
seem to be rather well separable in Fig. 4. Hence, in the spirit of
‘‘stacking’’ [26], we have trained another random forest for
Figure 1. Receiver Operating Characteristic (ROC) curves of the two-level random-forest classification approach. Solid curves:
averaged over ten-fold leave-one-patient-out cross-validation with random forests trained on interpolated Kyte-Doolittle hydrophobicity along
normalized sequences (green), on electrostatics hull (red), and on probability outputs of the two previous random forests, i.e. second-level
classification (blue); error-bars mark 95% confidence. Dashed curve: averages over ten out-of-bag predictions of second-level random forests on the
full training set of sequences, disregarding that several sequences may originate from same patient.
doi:10.1371/journal.pcbi.1000743.g001
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hydrophobicity random forests as inputs and again the measured
tropism classes as response.
This second-level classifier performed well (‘‘Combined’’ in
Fig. 1), with an AUC of 0:937+0:004 in leave-one-patient-out
cross-validation. The ROC curves in Fig. 4 have several
remarkable features. First, there is a striking difference between
the ROC curve from sequence-wise cross-validation (dashed) and
leave-one-patient-out cross-validation, with the first procedure
having a clearly higher performance (AUC~0:965+0:001). This
suggests that the algorithm perceptibly takes advantage of
similarities of sequences originating from the same patient.
Focusing therefore on the more conservatively estimated ROC
curve from patient-wise cross-validation, and on the region of low
false positive rates of, say, 0.1 and less, we find that both first-level
classifiers perform similarly well, and that in this region we also
have the strongest added value of the second-level classification of
the order of 10% in sensitivity.
The dataset used for training and cross-validation is composed
of sequences from several subtypes, and we could therefore study
the dependence of prediction performance of subtype. To this end
we set up a contingency table of subtypes (B, C, D, other) as rows,
and correct (T) and false (F) predictions in the cross-validation as
columns (for example see Supporting Information file Text S1).
We then carried out a x2-test with the null hypothesis of subtype-
independence of performance, as given by the Ts and Fs. This was
done for probability cutoffs between 0 and 1 in steps of 0.01 for the
assignment of a sequence to the tropism class X4. It turned out
that the p-value in all cases remained below 0:05, so that we
should accept at this significance level the alternative hypothesis:
performance depends on subtype. Specifically, the two-level
random forest performs somewhat better on subtypes C and D
than on subtype B (see also Supporting Information file Text S1).
Finally, one may ask whether classification with a single joint
descriptor set, encompassing both electrostatics and hydrophobic-
ity variables, could perform better than the two-level classification.
Theoretical and empirical results from other groups [27,28]
suggest that second-level learning on ensembles of classifiers
trained on different descriptor sets improves accuracy compared to
single-level learning. A possible advantage of single-level learning
with a joint descriptor set could be a consistent importance
analysis across all descriptors. However, it has recently been shown
that such an importance analysis in such a joint feature space is
biased, and thus may be difficult to interpret [29]. Despite these
caveats we tested classification with a single-level random forest
with joint descriptor set, and found a performance that was good,
but lower than that of the two-level approach; e.g. using the
sequence-wise cross-validation the two-level approach had an
AUC of 0:965+0:001, while the single-level random forest
achieved an AUC of 0:960+0:002, which is significantly lower
(p-value of 2:10{8 according to Wilcoxon test).
Comparison with other Methods
For comparison with other methods we compiled an
independent test set of recently published data comprising 74
sequences of various subtypes as described in the last section of
‘‘Materials and Methods’’. These data are disjunct to the training
set of the two-level classifier. As the data are recent, it is plausible
that they were also not included in the training sets of the other
machine-learning methods, though we cannot rule out this
inclusion.
Apart from our two-level method, we selected for comparison
the following methods: 11/25 [9,10], 11/24/25 [21], geno2pheno
[30], and wetcat [13], i.e. two simple rule-based and two machine-
learning methods, the latter two via their respective web-interfaces.
Since wetcat did not allow for cutoff changes, we took the
specificity of 0.98, resulting from the application of wetcat to the
independent test set, as reference specificity. We computed the
sensitivity of the two-level approach at this specificity. Choosing a
false positive rate of 1% as input parameter for geno2pheno
fortunately resulted also in a specificity of 0.98, so that the
sensitivities of all three machine learning methods could be
compared at the same specificity. Tab. 1 shows that the two-level
approach gives a higher sensitivity at this specificity than
geno2pheno and wetcat. For comparison with the two rule-based
methods we computed the sensitivities of the two-level approach at
the specificities of these methods. Tab. 1 shows that the two-level
approach has a higher sensitivity than the rule-based methods at
Figure 2. 5% most important positions on electrostatics hull for tropism classification by electrostatics based random forest. The
backbone of the template V3 conformation [15] is shown as tube with Ca atoms marked by small beads and some residues numbered for orientation,
starting with the N-terminal Cys as residue 1. Points are colored according to the mean electrostatic potential SwT (unit kB:300K=e) in the respective
tropism class (red, SwTƒ{2:5; light red, {2:5vSwTƒ{0:5; white, {0:5vSwTƒ0:5; light blue, 0:5vSwTƒ2:5; blue, 2:5vSwT).
doi:10.1371/journal.pcbi.1000743.g002
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surprisingly well.
The numbers in Tab. 1 should not be over-interpreted as the
size of the test dataset is rather limited. For instance, on the much
larger dataset used for patient-wise cross-validation of the two-level
approach (provided as Supporting Information), the sensitivity of
that approach was 0.762 at a specificity of 0.98, compared to the
sensitivity of 0.68 on the test dataset reported in Tab.1.
Conversely, the sensitivity of the 11/25 rule decreases as we go
from the smaller test set to the larger set from 0.71 (specificity 0.95)
to 0.53 (specificity 0.97).
Conclusions and Outlook
The high prediction performance suggests that tropism of the
investigated sequences can be attributed almost exclusively to
properties of V3, and that determinants outside V3 [31,32] may
be rare. Still, there remain a few instances of V3 sequences that
were misclassified after second-level learning. For instance, there
Figure 3. Importance of positions of normalized V3 sequence in random forest classification with Kyte-Doolittle descriptor [20]. The
higher the peak at the respective position, the more important this position for correct classification of sequences with respect to co-receptor
tropism. The most important region is around normalized sequence position 12, in agreement with the 11/25 rule. The second most important region
around position 8 could be involved in binding of sulfated tyrosine on CCR5 [23]. Along the top axis, reference sequence HXB2 before normalization
is given for orientation.
doi:10.1371/journal.pcbi.1000743.g003
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Fig. 4, i.e. both first-level classifiers, and therefore also the second-
level classifier, are almost certain to see a R5 sequence, while the
experimentally determined class is X4/R5X4. It is unclear
whether these remaining discrepancies are due to deficiencies of
our approach, tropism determinants outside the V3 loop, or
experimental errors.
Further points have to be considered in view of a clinical
application. First, most data for genotypic testing currently comes
from bulk sequencing of blood samples that in general can contain
mixtures of X4 and R5 virus. Since our method in its described
form is intended for clonal sequences, the predictive performance
on bulk sequencing data will be lower. Fortunately, due to the
current development of ‘‘deep’’ sequencing [33], more and more
clonal data will become available. Second, although sequences
from several subtypes were present in the training set, and a first
analysis of the influence of subtype was encouraging, it cannot be
excluded that the performance will drop if the method is applied to
subtypes that were not present in the learning set. In such cases,
the method should possibly be re-trained and tested anew. Third,
we have already mentioned above the occurrence of non-V3
determinants of co-receptor tropism as a possible source of errors.
Figure 4. X4 class probabilities for sequences as predicted by the two first-level random forests. Vertical and horizontal axis give
probabilities from electrostatics and hydrophobicity based random forests, respectively. These data points are the input for the second-level learning.
Note that the sets of R5-tropic sequences (circles) and X4/R5X4-tropic (crosses) can be separated quite well in the plane spanned by the two
descriptors.
doi:10.1371/journal.pcbi.1000743.g004
HIV Co-Receptor Tropism
PLoS Computational Biology | www.ploscompbiol.org 7 April 2010 | Volume 6 | Issue 4 | e1000743The frequency of such non-V3 determinants is not known, and it
could be even imagined that this frequency may change over time
due to a wider administration of entry inhibitors.
The presented method is based on training data comprising
sequences, protein structures, and outcomes of assays. This
mixture of data is available also for other cases of biological or
medical interest. For instance, it would be interesting to apply the
method to influenza, where structures and sequences of hemag-
glutinin and neuraminidase proteins responsible for contacts with
host cells are available, as well as many data from immunological
assays. An interesting question corresponding to prediction of co-
receptor tropism in HIV could be: Is an influenza virus with a
given set of protein sequences likely to infect bird, swine, or
human?
Materials and Methods
Sequences
For training and cross-validation all V3 sequences with tropism
information available from the Los Alamos HIV sequence
database (http://www.hiv.lanl.gov/) were retrieved. Sequences
were excluded from the analysis if they occurred with contradic-
tory tropism annotation in the database, if they contained non-
canonical amino-acid symbols, or if sequences were shorter than
30 residues. Duplicated sequences were included only once. R5X4
tropic viruses of non-clonal nature were excluded to avoid possible
discordance between genotyped sequence and sequence effectively
used in the phenotypical assay. These criteria led to 1151 R5
sequences, 166 X4 sequences, and 34 R5X4 sequences. 284 of
these sequences contained indels (17% of R5, 51% of X4, 10% of
R5X4). Most of the sequences came from subtypes B (619 R5, 81
X4/R5X4), C (218 R5, 14 X4/R5X4), and D (75 R5, 51 X4/
R5X4), with the rest (239 R5, 54 X4/R5X4) spread over many
different subtypes. In training and cross-validation, R5X4
sequences were assigned to the X4 class. All sequences used for
training and cross-validation are provided as Supporting Infor-
mation files Dataset S1 (R5), Dataset S2 (X4), and Dataset S3
(R5X4). For comparison with other methods an independent test
set was collected (see below ‘‘Comparison with other methods’’).
Structures and electrostatics
V3 structures were modeled using Modeller [34], version 9.6.
First, V3 sequences were subjected to pairwise alignment with the
V3 sequence in the X-ray structure by Huang et al. [15]. Based on
this alignment the structures of the V3 loops were modeled with
refinement limited to optimization of side-chain positions and
accommodation of insertions and deletions, if present. The Ca root
mean square deviation of the modeled structures to the template
on average was 0.085 nm with a standard deviation of 0.018 nm.
The electrostatic potential around the modeled structures was
computed by solving the Poisson-Boltzmann equation with APBS
[22] on a cubic grid with a spacing of 0.3 nm. PDB2PQR [35] was
used to determine charges and radii. Values for the dielectric
constant inside and outside V3 were scanned. Best results in the
tropism prediction were achieved with a value of e~5 both inside
and outside V3. Ionic strength was set to zero.
For the training of the machine learning model below, the
values of the electrostatic potential on a hull around the modeled
V3 structures was taken as input. The hull was defined as the set of
grid points with minimum distance to the solvent accessible surface
of the template V3 loop (solvent radius 0.14 nm) of n~1,2,3,:::
times the grid spacing distance, i.e. we tested hulls with distances of
0.3 nm, 0.6 nm, 0.9 nm, etc. to the solvent accessible surface. Best
results were obtained with a distance of 0.6 nm.
Machine Learning
Random forest analyses were carried out with the package
randomForest [17] of R [36]. ROC curves were analyzed with
package ROCr [37]. Cross-validation was performed in two ways.
Firstly, the out-of-bag error, as provided by the random forest
package was computed for the training and cross-validation set of
sequences described above (alternatively, we have employed ten-
fold external cross-validation but with essentially the same results).
The out-of-bag error is estimated by repeatedly bootstrapping
datasets, generating training sets comprising two thirds of these
datasets, and predicting the remaining third [17]. Secondly, we
have assessed the influence of sequence clusters originating from
the same patient by a leave-one-patient-out procedure, where the
random forest was trained on sequences of all patients except one,
and the tropisms of the sequence or sequences of this patient were
predicted; this was repeated with sequences of each patient being
used as test set once. If not mentioned otherwise performance
results reported in ‘‘Results/Discussion’’ refer to the leave-one-
patient-out procedure.
AUC values of the form a+d given in the text are averages over
ten random forest trainings with +d marking a 95% confidence
interval estimated with a t-distribution.
Comparison with other Methods
For comparative testing with other methods we collected from
recent publications [38–41] an independent test set. All sequences
from these publications were considered that did comply with the
criteria applied to the training dataset described above, and,
additionally were not already contained in that training set. In this
way we obtained a test set of 74 sequences (43 R5, 31 X4). The test
set contained sequences of subtypes B [39], AE [40], D [41], and
possibly A, C, D, F, G, H, J, AE, AG, CRF11, CRF12_BF,
CRF14_BG, URF from Ref. [38]. Since the last reference did not
contain assignments of sequences to subtypes, and as we had to
exclude some of the sequences from that reference because they
were already contained in our training set, the subtypes
contributed by Ref. [38] are not clear.
For the application of the 11/25 and 11/24/25 rule, sequences
were pairwisely aligned with the reference V3 sequence of the
HXB2 strain using Modeller [34]. HXB2 was taken from the Los
Alamos sequence database.
Table 1. Comparison with other methods on independent
test set.
Method Sensitivity Specificity Accuracy
geno2pheno 0.31 0.98 0.70
wetcat 0.63 0.98 0.83
two-level
a 0.68 0.98 0.86
11/25 0.71 0.95 0.85
two-level
b 0.73 0.95 0.86
11/24/25 0.75 0.83 0.80
two-level
c 0.81 0.83 0.82
Performance of several methods on the same test set of 74 sequences with
experimentally determined tropism. ‘‘Two-level’’ refers to the method described
in this paper which is used at three different specificities, (a) at specificity of
geno2pheno and wetcat, (b) at specificity of 11/25 rule, (c) at specificity of 11/
24/25 rule.
doi:10.1371/journal.pcbi.1000743.t001
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interfaces at http://coreceptor.bioinf.mpi-inf.mpg.de/ and http://
genomiac2.ucsd.edu:8080/wetcat/, respectively.
Supporting Information
Text S1 Supporting information on: subtype dependence of
prediction performance, statistics of multiple sequences originating
from same patient, and location of important regions of
electrostatics hull.
Found at: doi:10.1371/journal.pcbi.1000743.s001 (0.69 MB PDF)
Dataset S1 All V3-loop sequences (FASTA-format) of R5-tropic
virus used in the study for training and cross-validation.
Found at: doi:10.1371/journal.pcbi.1000743.s002 (0.07 MB
TXT)
Dataset S2 All V3-loop sequences (FASTA-format) of X4-tropic
virus used in the study for training and cross-validation.
Found at: doi:10.1371/journal.pcbi.1000743.s003 (0.01 MB
TXT)
Dataset S3 All V3-loop sequences (FASTA-format) of R5X4-
tropic (i.e. dualtropic) virus used in the study for training and
cross-validation.
Found at: doi:10.1371/journal.pcbi.1000743.s004 (2.00 KB TXT)
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